Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Skin inflammation can worsen intestinal inflammation and colitis.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

JAK inhibitors show promise in treating difficult skin diseases.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Different parts of the body have unique immune characteristics in their skin.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Inflammation damages sweat ducts, causing sweat gland injury.

Immune cells and cytokines significantly affect pathological scar development.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Hair growth phase in mice weakens certain immune responses.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Nanotechnology can improve tissue healing by controlling immune responses.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.